Lorviqua
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lorviqua, covering 2026-03-27 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Lorviqua (Lorlatinib) — Pfizer Europe MA EEIG
3 regulatory and trial events tracked for Lorviqua, covering 2026-03-27 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Lorviqua (Lorlatinib) — Pfizer Europe MA EEIG